Richard Haubrich

A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

Scott M. Hammer, David Katzenstein, Michael D. Hughes et al. · New England Journal of Medicine · 1996 · 1.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

Sharon A. Riddler, Richard Haubrich, A. Gregory DiRienzo et al. · New England Journal of Medicine · 2008 · 675 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response

Richard Haubrich, Susan J. Little, Judith S. Currier et al. · AIDS · 1999 · 551 citations

Public Health, Infectious Disease Control, Hiv Control +16

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial

José Valdez Madruga, Pedro Cahn, Beatriz Grinsztejn et al. · The Lancet · 2007 · 516 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +11

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

Bonaventura Clotet, Nicholas Bellos, Jean‐Michel Molina et al. · The Lancet · 2007 · 480 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +11